Company Filing History:
1 out of 167 
1 out of 822 
Years Active: 2015
Title: Hervë Geneste: Innovator in Phosphodiesterase Inhibitors
Introduction
Hervë Geneste is a notable inventor based in Ludwigshafen, Germany. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that target phosphodiesterase type 10A. His work has implications for treating various neurological and psychiatric disorders.
Latest Patents
Hervë Geneste holds a patent for "Inhibitor compounds of phosphodiesterase type 10A." This invention relates to compounds of a specific formula, including N-oxides, tautomers, prodrugs, and pharmaceutically acceptable salts. These compounds are designed to inhibit phosphodiesterase type 10A, making them suitable for the manufacture of medicaments aimed at treating or controlling medical disorders, including neurological and psychiatric conditions.
Career Highlights
Throughout his career, Hervë Geneste has worked with prominent companies in the pharmaceutical industry, including AbbVie Deutschland GmbH & Co. KG and AbbVie Inc. His experience in these organizations has allowed him to collaborate with other experts in the field and contribute to innovative solutions in medicine.
Collaborations
Hervë Geneste has collaborated with notable colleagues such as Michael Ochse and Karla Drescher. These partnerships have facilitated the advancement of research and development in the area of phosphodiesterase inhibitors.
Conclusion
Hervë Geneste's contributions to the field of medicinal chemistry, particularly through his patent on phosphodiesterase type 10A inhibitors, highlight his role as an innovator. His work continues to have a significant impact on the treatment of neurological and psychiatric disorders.